Abgenom, Inc. is an emerging
biotechnology research and product development company
that is focused on the discovery, development and
commercialization of novel, patent protected diagnostic
products with high clinical value.
specializes in developing innovative rapid diagnostic
tests tests/assays for clients. Our products range from
contract development to providing reagents necessary,
colloidal gold technologies, and various rapid
diagnostic devices for human and animal diseases, such
as cardiovascular disease and zoonoses.
is headquartered with offices, a Research and
Development Center and a state of the art production
facility in Wuhan, China.
successful biotech company cannot thrive without a
skilled research team capable of systematically
developing products that address pressing healthcare
needs. But, research expertise and commitment are not
the sole basis for success. Financial and marketing
counterparts, who excel at delivering a healthy bottom
line, are integral to a company’s performance.
Abgenom has established a highly experienced management
team with proven ability to balance the company’s
significant R&D requirements with the need to return
value to stockholders. The stability in our corporate
officer ranks is a testament to our pride in Abgenom’s achievements to date and confidence in our
long-term prospects. This kind of consistency and tenure
provides significant benefits to our customers,
shareholders and, more broadly, to the healthcare